N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide
C22H29ClFNOS — CID 170581270
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide
N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide (PubChem CID 170581270) has the molecular formula C22H29ClFNOS and a molecular weight of 410.00 g/mol. Its IUPAC name is N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide.
Molecular Properties
| Compound Name | N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide |
|---|---|
| PubChem CID | 170581270 |
| Molecular Formula | C22H29ClFNOS |
| Molecular Weight | 410.00 g/mol |
| Exact Mass | 409.16 |
| IUPAC Name | N-[(2-chloro-6-fluoro-3-methylphenyl)-(1-methylcyclopentyl)methyl]-6-thiaspiro[2.5]octane-2-carboxamide |
| SMILES | Cc1ccc(F)c(C(NC(=O)C2CC23CCSCC3)C2(C)CCCC2)c1Cl |
| InChI | InChI=1S/C22H29ClFNOS/c1-14-5-6-16(24)17(18(14)23)19(21(2)7-3-4-8-21)25-20(26)15-13-22(15)9-11-27-12-10-22/h5-6,15,19H,3-4,7-13H2,1-2H3,(H,25,26) |
| InChIKey | MFDJEPNSRUZTQB-UHFFFAOYSA-N |
| XLogP | 6.06 |
| TPSA | 29.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.00 |
| LogP ≤ 5 | 6.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170581270 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.